Clinical Scorecard: The Impact of Oncogenic Viruses on Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: A Comprehensive Review

At a Glance

Key Highlights

• HPV-positive oropharyngeal SCC shows improved survival compared to HPV-negative cases.
• HPV status is a key determinant in contemporary staging systems for OP SCC.
• Oncogenic mechanisms differ significantly between HPV-positive and HPV-negative tumors.
• HPV infection leads to extensive epigenetic changes and immune microenvironment alterations.
• The role of HPV in oral cavity SCC remains unclear and does not consistently confer prognostic benefits.

Guideline-Based Recommendations

Diagnosis

• Incorporate HPV status in the diagnostic evaluation of oropharyngeal SCC.

Management

• Consider HPV status when determining treatment strategies for OP SCC.

Monitoring & Follow-up

• Regular follow-up for HPV-positive patients due to differing prognostic outcomes.

Risks

• Tobacco and alcohol remain significant risk factors for oral cavity SCC.

Patient & Prescribing Data

Patients diagnosed with oral cavity and oropharyngeal squamous cell carcinoma.

HPV-positive tumors may respond better to radiotherapy and systemic therapies.

Clinical Best Practices

• Utilize standardized assessment frameworks for viral detection in SCC.
• Avoid direct extrapolation of OP SCC findings to OC SCC without proper stratification.

Related Resources & Content

• Comprehensive Review on Oncogenic Viruses and SCC